Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Halozyme Therapeutics

ClinicalTrials.gov Identifier:

NCT01453153

First received: October 13, 2011

Last updated: October 12, 2015

Last verified: September 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2015
Primary Completion Date:	February 2014 (Final data collection date for primary outcome measure)